Government services provider Perspecta Inc. and its partner, contract research organization and health sciences company PRA Health Sciences, have announced the successful launch of modernized tools in support of the Department of Veterans Affairs’ Million Veteran Program.
MVP is a national, voluntary research program funded by the VA Office of Research and Development, which aims to study how genes affect health. MVP is building one of the world’s largest medical databases, including blood samples and health information from more than 1 million veteran volunteers.
Perspecta and PRA together have delivered a software-as-a-service recruitment, enrollment, engagement and feedback solution. Known as MVP Online, the application was built by Perspecta on Clinical6, PRA’s SaaS mobile clinical trial platform for patient enrollment, engagement and data collection.
“While it is always gratifying to see our hard work come to fruition — seeing the potential reach and positive impact of our work is most fulfilling,” said Mac Curtis, Perspecta president and CEO. “MVP Online will be an incredibly useful tool for the VA today, but will also serve as a platform to allow current veterans to help transform health care for future generations of veterans to come.”
MVP Online will enable veterans to learn about the program, read testimonials and enroll in the program. It will replace the existing paper processes through a single website, enabling VA to better engage, recruit and increase retention in the MVP program.
“The MVP Online program and the data coming from the program has the chance to drastically improve the health and wellbeing of our country’s veterans,” said Kent Thoelke, chief scientific officer and executive vice president at PRA Health Sciences.
“As health care continues to evolve, it is essential that we focus on impactful ways to engage with veterans digitally from their homes or anywhere in the world, so they can enroll in research faster, stay engaged with their caregivers and get better overall treatment,” he added.